Skip to content
drillr.ai
Sign up

BCLI

Brainstorm Cell Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.05
−1.87%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+40.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 28, 2026FRENKEL JACOB A · directorA-Award100,000$0.00
Jul 28, 2026Pitts Peter Joe · director, officer: Executive ChairmanA-Award900,000$1.00
May 29, 2026Patlis Alla · officer: See RemarksA-Award100,000$0.00
May 29, 2026Lebovits Chaim · officer: President & CEOA-Award1,800,000$0.00
May 29, 2026ARBEL IRIT · directorA-Award120,000$0.00
May 29, 2026FRENKEL JACOB A · directorA-Award200,000$0.00
May 29, 2026Yablonka Uri · director, officer: EVP & Chief Business OfficerA-Award150,000$0.00
May 20, 2026Bairu Menghisteab · directorA-Award150,000$0.70
May 20, 2026Dagher Ibrahim B. · directorA-Award225,000$0.70
May 20, 2026Naor Nir · directorA-Award180,000$0.70
May 20, 2026Lindborg Stacy · directorA-Award150,000$0.70
May 20, 2026HARTOUNIAN HARTOUN · directorA-Award225,000$0.70
May 20, 2026Polverino Anthony J. · directorA-Award150,000$0.70
Jan 7, 2025Dagher Ibrahim B. · officer: Chief Medical OfficerA-Award50,000$0.00
Jan 3, 2025Polverino Anthony J. · directorA-Award24,000$0.00
Jan 3, 2025Lindborg Stacy · directorA-Award20,000$0.00
Jan 3, 2025Yablonka Uri · director, officer: EVP & Chief Business OfficerA-Award20,000$0.00
Jan 3, 2025Yablonka Uri · director, officer: EVP & Chief Business OfficerA-Award40,000$0.00
Jan 3, 2025Patlis Alla · officer: See RemarksA-Award40,000$0.00
Jan 3, 2025HARTOUNIAN HARTOUN · officer: EVP, Chief Operating OfficerA-Award50,000$0.00
Jan 3, 2025Bairu Menghisteab · directorA-Award24,000$0.00
Jan 3, 2025ARBEL IRIT · directorA-Award30,666$0.00
Jan 3, 2025Naor Nir · directorA-Award30,666$0.00
Jan 3, 2025Lebovits Chaim · officer: President & CEOA-Award120,000$0.00
Jan 3, 2025FRENKEL JACOB A · directorA-Award40,000$0.00
Oct 2, 2024Lebovits Chaim · officer: President & CEOPurchase1,836$3.43
Oct 2, 2024Lebovits Chaim · officer: President & CEOPurchase22,000$0.23
Jul 31, 2024Lebovits Chaim · officer: President & CEOPurchase15,000$0.52
Jul 31, 2024Lebovits Chaim · officer: President & CEOPurchase130,000$0.55
Jul 31, 2024Lebovits Chaim · officer: President & CEOPurchase115,072$0.53

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 28, 2026